OptiNose, Inc. - Common Stock (NQ:OPTN)

9.600 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about OptiNose, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps

March 15, 2024

From Optinose, Inc.

Via GlobeNewswire

OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023 ↗

March 07, 2024

OPTN stock results show that OptiNose met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.

Via InvestorPlace

Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights

March 07, 2024

From Optinose, Inc.

Via GlobeNewswire

Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results

February 29, 2024

Conference Call and Webcast to be held March 7, 2024, at 8:00 a.m. Eastern Time

From Optinose, Inc.

Via GlobeNewswire

Earnings Scheduled For March 7, 2024 ↗

March 07, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Via Benzinga

OptiNose's Earnings: A Preview ↗

March 06, 2024

Via Benzinga

Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice

January 18, 2024

From Optinose, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 06, 2023

Via Benzinga

Gold Moves Higher; Campbell Soup Earnings Top Expectations ↗

December 06, 2023

U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.

Via Benzinga

Topics Stocks

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 06, 2023

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 06, 2023

Via Benzinga

Crude Oil Down 4%; Pharvaris Shares Spike Higher ↗

December 06, 2023

U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,...

Via Benzinga

Topics Stocks

US Stocks Higher; Private Payrolls Rise By 103,000 In November ↗

December 06, 2023

U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%...

Via Benzinga

Topics Stocks

Why ENT-Focused OptiNose Shares Are Diving Today ↗

December 06, 2023

OptiNose, Inc. (NASDAQ: OPTN) shares are trading lower after the company announced a three-month extension of the FDA review period for the supplemental new drug application for

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 06, 2023

Via Benzinga

Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE

December 06, 2023

From Optinose, Inc.

Via GlobeNewswire

Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

November 22, 2023

From Optinose, Inc.

Via GlobeNewswire

Optinose Reports Third Quarter 2023 Financial Results and Operational Updates

November 09, 2023

From Optinose, Inc.

Via GlobeNewswire

Optinose Announces Reporting Date for Third Quarter 2023 Financial Results

October 27, 2023

Conference Call and Webcast to be held November 9, 2023, at 8:00 a.m. Eastern Time

From Optinose, Inc.

Via GlobeNewswire

Optinose to Present at the 2023 Cantor Global Healthcare Conference

September 22, 2023

From Optinose, Inc.

Via GlobeNewswire

Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023 ↗

August 21, 2023

Via Benzinga

Optinose Reports Second Quarter 2023 Financial Results and Operational Updates

August 10, 2023

From Optinose, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 28, 2023

Via Benzinga

Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million

July 27, 2023

From Optinose, Inc.

Via GlobeNewswire

Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 16, 2023

From Optinose, Inc.

Via GlobeNewswire

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 07, 2023

On Wednesday, 29 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 06, 2023

On Tuesday, 69 stocks hit new 52-week lows.

Via Benzinga

Optinose to Present at the Jefferies Healthcare Conference

June 02, 2023

From Optinose, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Friday ↗

May 19, 2023

On Friday, 63 companies hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.